Amlodipine And Valsartan Tablet
Product Images NDC 33342-279

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 33342-279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

543 (Amlodipine Valsartan Tab 10 160mg 90s Count)

Label for Amlodipine and Valsartan Tablets USP 10 mg / 160 mg by Macleods Pharmaceuticals Limited. The oral tablet package contains 90 film-coated tablets. Label includes active ingredient strengths, storage instructions, manufacturer and labeler information, and dosage guidance note.*

FDA Label Image

876 (Amlodipine Valsartan Tab 10 320mg 30s Count)

Label for amlodipine and valsartan tablets, USP with a strength of 10 mg/320 mg. The label shows product name, manufacturer Macleods Pharma USA and Macleods Pharmaceuticals Ltd, package size of 30 tablets, and storage instructions at 20° to 25°C. It includes active ingredient details and barcodes.*

FDA Label Image

111 (Amlodipine Valsartan Tab 5 160mg 30s Count)

Label for Amlodipine and Valsartan Tablets, USP, containing 5 mg amlodipine and 160 mg valsartan per tablet. The product is supplied as 30 tablets per package, manufactured by Macleods Pharmaceuticals Ltd. The label includes storage instructions and dosage reference information.*

FDA Label Image

778 (Amlodipine Valsartan Tab 5 160mg 90s Count)

Label for Amlodipine and Valsartan Tablets, USP 5 mg/160 mg film-coated tablets. The label states the active ingredients with strengths, manufacturer is Macleods Pharmaceuticals Ltd., and it contains 90 tablets. Storage instructions and dosage information references are included on the label.*

FDA Label Image

555 (Amlodipine Valsartan Tab 5 320mg 30s Count)

Label for Amlodipine and Valsartan Tablets, USP, 5 mg/320 mg, oral tablet dosage form. The label shows the Macleods Pharma USA logo and indicates the product contains 30 tablets. It notes the active ingredients: amlodipine besylate equivalent to 5 mg amlodipine and 320 mg valsartan per tablet. Storage instructions and manufacturer details for Macleods Pharmaceuticals Ltd., India, are included.*

FDA Label Image

432 (Amlodipine Valsartan Tab 5 320mg 90s Count)

Label for Amlodipine and Valsartan Tablets USP, 5 mg/320 mg, oral tablet form. The label indicates the product is manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. It includes dosage information, storage conditions, barcodes, and states the package contains 90 tablets.*

FDA Label Image

Amlodipine-valsartan-tab-amlo-api-str (Amlodipine Valsartan Tab Amlo Api Str)

Chemical structure diagram of the active ingredients amlodipine and valsartan, showing molecular components labeled with chemical groups and atoms.*

FDA Label Image

Amlodipine-valsartan-tab-fig1 (Amlodipine Valsartan Tab Fig1)

A line graph depicting the percentage of subjects with systolic blood pressure (SBP) under 140 mmHg against baseline SBP values ranging from 140 to 180 mmHg. Four curves represent different treatments: Amlodipine and Valsartan 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, illustrating comparative blood pressure control efficacy.*

FDA Label Image

Amlodipine-valsartan-tab-fig2 (Amlodipine Valsartan Tab Fig2)

A line graph comparing percentage of patients with diastolic blood pressure (DBP) less than 90 mmHg across baseline DBP values. Four data series are shown: amlodipine and valsartan 10/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo. The graph illustrates relative performance of these treatments over baseline DBP ranging from 95 to 110 mmHg.*

FDA Label Image

Amlodipine-valsartan-tab-fig3 (Amlodipine Valsartan Tab Fig3)

A scatter plot chart comparing the percentage of subjects with systolic blood pressure less than 130 mmHg against baseline systolic blood pressure (mmHg) for four groups: Amlodipine and Valsartan 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The chart uses different symbols to represent each treatment group, showing trends across baseline systolic blood pressure values ranging from approximately 140 to 180 mmHg.*

FDA Label Image

Amlodipine-valsartan-tab-fig4 (Amlodipine Valsartan Tab Fig4)

A line graph comparing the percentage of diastolic blood pressure (DBP) less than 90 mmHg across baseline DBP values (90-110 mmHg) for four treatments: amlodipine and valsartan 10/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo. The graph shows a decreasing trend for all treatments as baseline DBP increases, with amlodipine and valsartan combination showing the highest percentages throughout.*

FDA Label Image

Amlodipine-valsartan-tab-val-api-str (Amlodipine Valsartan Tab Val Api Str)

Chemical structure diagram of the active ingredient amlodipine, showing its molecular configuration with labeled carbon, hydrogen, nitrogen, and oxygen atoms as part of the compound's standard skeletal formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.